Hudson Bay Capital Management
ZVSAW

Hudson Bay Capital Management’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Hudson Bay Capital Management’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-398,250
Closed -$48K – 1285
2022
Q3 		$48K Sell
398,250
-126,750
-24% -$16.4K ﹤0.01% 977
2022
Q2 		$53K Hold
525,000
– – ﹤0.01% 1080
2022
Q1 		$90K Buy
+525,000
New +$106K ﹤0.01% 955

Hudson Bay Capital Management's ZVSAW Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 398,250 shares — an estimated $48K sold.

Hudson Bay Capital Management first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $90K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Hudson Bay Capital Management reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 398,250 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $48K.
  • Hudson Bay Capital Management first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
  • Hudson Bay Capital Management's ZyVersa Therapeutics, Inc. Warrants position peaked at $90K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.